COVID-19Regulatory

Trump administration backs giving experimental coronavirus therapies to patients

by Cassidy Morrison | March 19, 2020

President Trump announced Thursday that the Food and Drug Administration would soon introduce new coronavirus therapies.

Trump announced that the FDA is “slashing all of the red tape” to get medicines on the market “as fast as we can get it.” Anti-viral therapies are still in early clinical trials, but the Trump administration is aiming to speed up the process.

“What the FDA is doing is incredible,” Trump said. “I’ve directed the FDA to eliminate outdated rules and bureaucracy. … We have to remove every barrier.”

The FDA is considering a drug used to treat malaria called Chloroquine, which researchers think could prove an effective treatment for the coronavirus. Trump said it has “tremendous promise based on results and other tests.” Another drug that could be used to treat the coronavirus is Remdesivir, an antiviral made by Gilead, the manufacturer behind PrEP drugs to prevent HIV infection.

READ THE REST HERE

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button